Pharmacologic management of urinary incontinence, voiding dysfunction, and overactive bladder

Obstetrics and Gynecology Clinics of North America
Emily K Saks, Lily A Arya

Abstract

Most drugs used in the treatment of urinary incontinence and voiding dysfunction in women modulate neuromuscular transmission in the urethra and bladder. Pharmacotherapy is the mainstay of treatment for overactive bladder. Although several different antimuscarinic medications are available for the treatment of overactive bladder, most have similar efficacy and tolerability. Pharmacotherapy has a limited role in the management of stress incontinence and voiding dysfunction in women. Newer drugs that target different mechanisms of action are being developed for the treatment of urinary incontinence and voiding dysfunction in women.

References

May 1, 1975·Urology·A C Diokno, M Taub
Jun 12, 1987·JAMA : the Journal of the American Medical Association·N M Resnick, S V Yalla
Sep 1, 1996·Baillière's Clinical Obstetrics and Gynaecology·J Schaffer, J A Fantl
Apr 21, 1999·The Journal of Urology·V W NittiJ Gitlin
Dec 16, 2000·Expert Opinion on Investigational Drugs·A J Wein
Mar 15, 2001·Urology·P Van KerrebroeckUNKNOWN Tolterodine Study Group
Apr 11, 2001·International Urogynecology Journal and Pelvic Floor Dysfunction·L CardozoH de Koning Gans
Jun 9, 2001·Urological Research·J M Hunsballe, J C Djurhuus
Nov 22, 2001·International Urogynecology Journal and Pelvic Floor Dysfunction·P J WoodmanJ R Fischer
Jan 5, 2002·World Journal of Urology·K E Andersson, C R Chapple
Jul 13, 2002·American Journal of Obstetrics and Gynecology·Peggy A NortonUNKNOWN Duloxetine Urinary Incontinence Study Group
Dec 13, 2002·The Urologic Clinics of North America·Alan J Wein, Eric S Rovner
Jul 10, 2003·Obstetrics and Gynecology·Richard C BumpUNKNOWN Duloxetine Urinary Incontinence Study Group
Aug 11, 2005·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Yanni F YuJeonghoon Ahn
Dec 21, 2005·Drugs & Aging·Dene Simpson, Antona J Wagstaff
Feb 9, 2006·British Journal of Pharmacology·Sharath S Hegde
May 30, 2006·The American Journal of Geriatric Pharmacotherapy·Adrian WaggPaul Sieber
Oct 3, 2006·The Urologic Clinics of North America·Ananias Diokno, Michael Ingber
Jan 3, 2007·Journal of the American Geriatrics Society·John A Taylor, George A Kuchel
May 22, 2007·BJU International·William D SteersUNKNOWN Duloxetine OAB Study Group
Aug 21, 2007·Neurourology and Urodynamics·Francisco Cruz, Paulo Dinis
Oct 18, 2007·International Journal of Clinical Practice. Supplement·H Hashim, P Abrams
Oct 17, 2007·The Journal of Urology·Victor W NittiTamara Bavendam
Apr 22, 2008·BJU International·Richard C BumpWei Chen
May 24, 2008·The Journal of Urology·Linda BrubakerUNKNOWN Pelvic Floor Disorders Network
Jul 24, 2008·BJU International·Christopher R ChappleMarina Brodsky
Sep 4, 2008·Expert Opinion on Emerging Drugs·Marcus J Drake

❮ Previous
Next ❯

Citations

Jan 17, 2012·International Urogynecology Journal·Joy A GreerLily A Arya
May 14, 2016·International Braz J Urol : Official Journal of the Brazilian Society of Urology·Jose Carlos TruzziRicardo Reges
Nov 2, 2013·World Journal of Stem Cells·Hatim Thaker, Arun K Sharma
Jul 1, 2014·Female Pelvic Medicine & Reconstructive Surgery·Lucio M A CipulloMaurizio Guida
Jun 10, 2011·Current Opinion in Urology

❮ Previous
Next ❯

Related Concepts

Related Feeds

Ataxia

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on ataxia here.

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Botulism (ASM)

Botulism is a rare but serious paralytic illness caused by a nerve toxin that is produced by the bacterium clostridium botulinum. Discover the latest research on botulism here.

Ataxias (MDS)

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on ataxia here.

Botulism

Botulism is a rare but serious paralytic illness caused by a nerve toxin that is produced by the bacterium clostridium botulinum. Discover the latest research on botulism here.

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.